Catheter Precision, Inc. (VTAK)

Market Cap	3.64M
Revenue (ttm)	442,000
Net Income (ttm)	-71.37M
Shares Out	7.57M
EPS (ttm)	-12.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,380
Open	0.450
Previous Close	0.443
Day's Range	0.443 - 0.498
52-Week Range	0.340 - 1.550
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 31, 2024

About VTAK

Catheter Precision, Inc. develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retent...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 30, 2018
• Employees: 14
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: VTAK

Financial Performance

In 2023, VTAK's revenue was $442,000, an increase of 3057.14% compared to the previous year's $14,000. Losses were -$71.37 million, 165.7% more than in 2022.